Navigation Links
New Garlic Product Mimics Garlic to Perfection

Clinical trials have come up with novel methods to study 'better than nature' methods to study the effects of a commercial// garlic product in maintaining a healthy cardiovascular system without the typical side effects of using raw garlic.

A recent study presented at the Annual Meeting of the American College of Nutrition today reveals that amounts equal to that of fresh high allicin garlic macerate can be delivered to the body by a new proprietary garlic product developed by Nutra Products, Inc., Garli-Eze?. Allicin, is the chief bioactive ingredient of garlic. It was established in the study that all untoward effects of chewing fresh garlic were avoided when using this new garlic propriety product.

By nature a very short lived bioactive substance, allicin requires complicated and highly sophisticated methods to assess its presence in a product. A method developed by Dr. Larry Lawson, a world renowned garlic researcher, was used in the study the results of which was published as a decisive research article in 2005 in the Journal of Agricultural and Food Chemistry. . This method employs a highly sensitive method of analyzing the breath after ingestion of garlic and unequivocally can determine if garlic was both delivered to the body for absorption, and its subsequent absorption.

Dr. Rick Falkenberg, Chief Technical Officer of Nutra Products Inc., the maker of Garli-Eze?, "Allicin is the only known key biologically active compound of fresh crushed garlic. We believe a high level of allicin delivered directly to the gastrointestinal tract is a key to helping maintain a healthy cardiovascular system. This preliminary human study indicates that Garli-Eze? can deliver large amounts of allicin directly to the upper gastrointestinal tract where it can be easily absorbed. Using innovative state-of-the-art manufacturing we have developed a process that delivers as much natural allicin as fresh garlic without offensive odors or discomf
'"/>




Page: 1 2

Related medicine news :

1. More to Garlic than warding of Dracula
2. Garlic a day keeps cancer away
3. Garlic fights malaria and cancer
4. Garlic Supplements Impede HIV Therapy
5. Vegetables And Garlic Confer Protection From Skin Cancer
6. Another Feather In The Garlic Cap: Helpful In Avoiding Breast Cancer
7. Garlic inhibits fungal growth and protects food
8. Garlic Helps To Reduce Cholesterol in Rats
9. Garlic compound may help treat cancer
10. Onions, Garlic may Reduce the Risk of Cancer
11. Garlic may Not Aid in Heart Disease and Cholesterol Levels
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Garlic Product Mimics Garlic Perfection

(Date:11/26/2014)... Increasing demand for diagnostic imaging ... surgeries has paved way for consequent increase in ... various types of cancers and cardiac diseases globally ... for these owing to their use in diagnosing ... market can also be attributed to advancements in ...
(Date:11/26/2014)... Gone are the days when throngs of shoppers flood ... signifies the beginning of the Christmas shopping season. Instead, shoppers ... the comfort of their homes or on the go, away ... to be an occasion with one of the fastest growing ... in revenue for online retailers according to Adobe Digital Index. ...
(Date:11/26/2014)... 26, 2014 With a redesign of ... Steven Meier has enhanced the user experience and ... prospective patients an online destination for orthopedic and sports ... present the new and improved version of the website. ... easier than ever for current and prospective patients to ...
(Date:11/26/2014)... Sonru, the video interviewing specialist, has today announced the ... Marketing Officer, in addition to the formal opening of ... been appointed as Chief Operating Officer. He is joined ... Marketing Officer. , Mr Jones is a seasoned tech, ... roles with The Walt Disney Company and Adventis where ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 Medical suction ... 3.9 out of 5. This score represents steady growth ... three years to 2014 as a result of swelling ... suction machines, which are largely considered nondiscretionary. IBISWorld market ... process, buyers have some degree of flexibility, given the ...
Breaking Medicine News(10 mins):Health News:Contrast Media Injectors Market To 2020 - Global Industry, Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 2Health News:Contrast Media Injectors Market To 2020 - Global Industry, Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 3Health News:2014 Best Friday Deals Revealed by Top10InAction 2Health News:Los Angeles Orthopedic Surgeon Dr. Steven Meier Announces Relaunch Of Practice Website 2Health News:Sonru Expansion continues with appointment of new executive team and opening of new London base 2Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 4
... a $65,000 grant to a newly hired Virginia Tech College ... of data collection during a catastrophe such as the recent ... Jules White, with the Bradley Department of Electrical & ... that would rely on information captured by "citizen scientists" who ...
... Case Medical Center is offering new hope for patients ... untreatable through a revolutionary technology called AutoLITT which "cooks" ... one of only three medical centers in the world ... fight against cancer. It is especially effective in ...
... News) -- Young people with the kind of irregular heartbeat ... to fix the problem instead of taking medication first, a ... pulse rate to change from minute to minute, can boost ... is rare in younger people and can occur for no ...
... 22, 2010) Dutch biopharmaceutical company Crucell N.V. (Euronext, ... TB Vaccine Foundation today announced the start of a ... developed tuberculosis (TB) vaccine candidate, AERAS-402/Crucell Ad35. ... the safety and efficacy of the TB vaccine candidate ...
... conducted at Oregon Health & Science University,s Vaccine and ... associated with administering a specific compound in some forms ... current edition of Cell Host and Microbe . ... Jay Nelson, Ph.D., studies human cytomegalovirus, a virus that ...
... real time radiology services virtually anywhere, anytime. ... portable interface system that delivers images, electronic medical ... any internet-ready device. Virtual Viewbox ensures HIPAA ... offers a timely solution to the newly activated ...
Cached Medicine News:Health News:Researcher seeks to create 'citizen scientists' to help in response to environmental disasters 2Health News:University Hospitals Case Medical Center implements AutoLITT system for treatment of brain tumors 2Health News:Surgery May Be Best for Irregular Heartbeat in Young 2Health News:Aeras and Crucell announce Phase II clinical trial start in Kenya 2Health News:Aeras and Crucell announce Phase II clinical trial start in Kenya 3Health News:Aeras and Crucell announce Phase II clinical trial start in Kenya 4Health News:OHSU research suggests compound administered during some bone marrow transplants elevates risks 2Health News:Virtual Viewbox offers portable radiology access for physicians 2
(Date:11/26/2014)... November 26, 2014 Investor-Edge has initiated ... VVUS ), Horizon Pharma PLC (NASDAQ: HZNP ), ... (NYSE: JNJ ), and Theravance Inc. (NASDAQ: ... be accessed at: http://investor-edge.com/register . On Tuesday, ... 0.07%, the Dow Jones Industrial Average edged 0.02% lower, to ...
(Date:11/26/2014)... SHANGHAI , Nov. 26, 2014  CARsgen, a ... (CAR-T) cell immunotherapy to treat a variety of cancers, ... led by BVCF, a China -based ... an immunotherapy company focused on the development of new ... collaboration with Shanghai Cancer Institute and Shanghai Renji Hospital, ...
(Date:11/26/2014)... -- At the American Dental Association,s Annual Meeting in ... Group was honored to be part of the 2014 ... see and test the Best of Class winners and ... the latest developments in dental technology. This year, featured ... Caries Detection Device and Kerr Demi ™  Ultra ...
Breaking Medicine Technology:Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5CARsgen Completes Series A Financing 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 3
... Study Now Underway at Nine,Centers, SAN DIEGO, Calif., ... company, today presented long term,follow-up data from a ... product in development for the treatment of Parkinson's,disease, ... at 12 months after administration, as measured,by the ...
... 2007 - Antigenics Inc.,(NASDAQ: AGEN) today announced ... Phase 1/2 investigator-sponsored trial of the company's,investigational ... at the 75th annual meeting of the,American ... results from the study, being conducted at ...
Cached Medicine Technology:Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of,CERE-120 Demonstrating Improved Motor Function in Parkinson's,Patients 2Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of,CERE-120 Demonstrating Improved Motor Function in Parkinson's,Patients 3Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of,CERE-120 Demonstrating Improved Motor Function in Parkinson's,Patients 4Data from Investigator-Sponsored Trial of Oncophage Cancer Vaccine,in Glioma Presented at American Association of Neurological,Surgeons Annual Meeting 2Data from Investigator-Sponsored Trial of Oncophage Cancer Vaccine,in Glioma Presented at American Association of Neurological,Surgeons Annual Meeting 3Data from Investigator-Sponsored Trial of Oncophage Cancer Vaccine,in Glioma Presented at American Association of Neurological,Surgeons Annual Meeting 4
As pupil size continues to play a significant role in the outcomes of refractive surgery, the pre-operative use of the Colvard Pupillometer continues to be the standard of care for obtaining accurate...
Subretinal Injection Cannula, Curved; 20g (0.90) x 1" (25mm); Tip Extension: 3mm, 32g (0.23); Angled at 35°....
Silicone Oil Cannula; 16g (1.40) x 8mm....
...
Medicine Products: